dc.contributor.author | Mian, H | |
dc.contributor.author | Grant, SJ | |
dc.contributor.author | Engelhardt, M | |
dc.contributor.author | Pawlyn, C | |
dc.contributor.author | Bringhen, S | |
dc.contributor.author | Zweegman, S | |
dc.contributor.author | Stege, CAM | |
dc.contributor.author | Rosko, AE | |
dc.contributor.author | von Lilienfeld-Toal, M | |
dc.contributor.author | Wildes, TM | |
dc.date.accessioned | 2020-09-30T14:30:44Z | |
dc.date.issued | 2020-06-01 | |
dc.identifier.citation | Journal of geriatric oncology, 2020, 11 (5), pp. 764 - 768 | |
dc.identifier.issn | 1879-4068 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/4117 | |
dc.identifier.eissn | 1879-4076 | |
dc.identifier.doi | 10.1016/j.jgo.2020.04.008 | |
dc.format | Print-Electronic | |
dc.format.extent | 764 - 768 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | ELSEVIER | |
dc.subject | Humans | |
dc.subject | Pneumonia, Viral | |
dc.subject | Coronavirus Infections | |
dc.subject | Multiple Myeloma | |
dc.subject | Aged | |
dc.subject | Pandemics | |
dc.subject | Betacoronavirus | |
dc.subject | COVID-19 | |
dc.subject | SARS-CoV-2 | |
dc.title | Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2020-04-16 | |
rioxxterms.versionofrecord | 10.1016/j.jgo.2020.04.008 | |
rioxxterms.licenseref.startdate | 2020-06 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Journal of geriatric oncology | |
pubs.issue | 5 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Myeloma Biology and Therapeutics | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Myeloma Biology and Therapeutics | |
pubs.publication-status | Published | |
pubs.volume | 11 | |
pubs.embargo.terms | Not known | |
icr.researchteam | Myeloma Biology and Therapeutics | |
dc.contributor.icrauthor | Pawlyn, Charlotte | |